Prevalence of Silent Ischemia in Diabetic Patients with Coronary Artery Disease

Aroob Hashmat; Roshan Nadeem; Mahnoor Hamid; Rabia Batool; Muhammad Hamza Riaz; Iman Ikram

doi:10.70749/ijbr.v3i4.1027

Authors

Aroob Hashmat Department of General Medicine, Sheikh Zayed Hospital, Rahim Yar Khan, Punjab, Pakistan.
Roshan Nadeem Department of Emergency Medicine, City Medical Center Lalamusa, Punjab, Pakistan.
Mahnoor Hamid Department of Internal Medicine, Combined Military Hospital (CMH), Lahore, Punjab, Pakistan.
Rabia Batool Basic Health Unit, Mangriot Sudhnoti, Pakistan.
Muhammad Hamza Riaz ICU, Social Security Teaching Hospital, Lahore, Punjab, Pakistan.
Iman Ikram Department of Medicine, Shalamar Hospital, Lahore, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i4.1027

Keywords:

Silent Ischemia, Diabetes Mellitus, Coronary Artery Disease, Prevalence Study

Abstract

Background: Silent myocardial ischemia, defined as objective evidence of myocardial ischemia without anginal symptoms, is commonly observed in patients with diabetes mellitus due to autonomic neuropathy and vascular dysfunction. Objective: To determine the prevalence of silent myocardial ischemia in diabetic patients with angiographically confirmed coronary artery disease and to assess its association with clinical and metabolic risk factors. Methods: This cross-sectional observational study was conducted at Social Security Teaching Hospital Lahore from August 2024 to January 2025. A total of 205 patients were added to the study. Data were collected through a detailed clinical assessment of patients, including history, physical examination, and evaluation of cardiovascular risk factors (hypertension, dyslipidemia, smoking status, family history of CAD, etc.). Glycemic control was assessed using fasting plasma glucose and HbA1c levels. Results: Silent ischemia was detected in 84 patients, indicating a prevalence of 41.0%. The condition was more prevalent among patients with HbA1c ≥8.0% (47.2%) compared to those with HbA1c <8.0% (33.7%), although the association was not statistically significant (p = 0.4335). A higher prevalence was observed in patients with longer duration of diabetes (>10 years: 49.4%) and those with diabetic neuropathy (54.3%). Myocardial perfusion imaging yielded a higher detection rate (50.7%) compared to ETT (35.6%). Silent ischemia was significantly more common in patients with multiple cardiovascular risk factors (≥3 risk factors: 51.7%). Conclusion: It is concluded that silent myocardial ischemia is highly prevalent among diabetic patients with CAD, particularly those with poor glycemic control, long-standing diabetes, neuropathy, and multiple risk factors.

Downloads

Download data is not yet available.

References

Hernández, C., Candell-Riera, J., Ciudin, A., Francisco, G., Aguadé-Bruix, S., & Simó, R. (2011). Prevalence and risk factors accounting for true silent myocardial ischemia: A pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovascular Diabetology, 10(1). https://doi.org/10.1186/1475-2840-10-9

Ihsan, A., & Khan, S. B. (2022). SILENT MYOCARDIAL ISCHEMIA AMONG ASYMPTOMATIC TYPE-2 DIABETIC PATIENTS. Journal of Postgraduate Medical Institute, 36(1), 20–24. https://doi.org/10.54079/jpmi.36.1.2896

Henning, R. J. (2018). Type-2 diabetes mellitus and cardiovascular disease. Future Cardiology, 14(6), 491-509. https://doi.org/10.2217/fca-2018-0045

Hernández, C., Candell-Riera, J., Ciudin, A., Francisco, G., Aguadé-Bruix, S., & Simó, R. (2011). Prevalence and risk factors accounting for true silent myocardial ischemia: A pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovascular Diabetology, 10(1). https://doi.org/10.1186/1475-2840-10-9

Khafaji, H. A. (2014). Atypical presentation of acute and chronic coronary artery disease in diabetics. World Journal of Cardiology, 6(8), 802. https://doi.org/10.4330/wjc.v6.i8.802

Prasad, D., Kabir, Z., Revathi Devi, K., Peter, P. S., & Das, B. (2019). Prevalence and risk factors for silent myocardial ischemia (PRISM): A clinico observational study in patients of type 2 diabetes. Indian Heart Journal, 71(5), 400-405. https://doi.org/10.1016/j.ihj.2019.12.002

Baweja, P. S., Sandesara, P. B., & Ashraf, M. J. (2014). Asymptomatic coronary artery disease in type II diabetes. Missouri Medicine, 111(1), 73. https://pmc.ncbi.nlm.nih.gov/articles/PMC6179518/

Young, L. H., Wackers, F. J., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., Ratner, R. E., Inzucchi, S. E., & DIAD Investigators, F. T. (2009). Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA, 301(15), 1547. https://doi.org/10.1001/jama.2009.476

Sheikh, A., Faisal, S. S., & Jabbar, A. (2011). Frequency of silent myocardial ischaemia in diabetics: a single centre study. Journal of the Pakistan Medical Association, 61(10), 1037. https://ecommons.aku.edu/pakistan_fhs_mc_med_diabet_endocrinol_metab/4

Singleton, M. J., German, C. A., Bertoni, A. G., Ambrosius, W. T., Bhave, P. D., Soliman, E. Z., & Yeboah, J. (2020). Association of silent myocardial infarction with major cardiovascular events in diabetes: The ACCORD trial. Diabetes Care, 43(4), e45-e46. https://doi.org/10.2337/dc19-2201

Vähätalo, J. H., Huikuri, H. V., Holmström, L. T., Kenttä, T. V., Haukilahti, M. A., Pakanen, L., Kaikkonen, K. S., Tikkanen, J., Perkiömäki, J. S., Myerburg, R. J., & Junttila, M. J. (2019). Association of silent myocardial infarction and sudden cardiac death. JAMA Cardiology, 4(8), 796. https://doi.org/10.1001/jamacardio.2019.2210

Valensi, P., & Meune, C. (2019). Congestive heart failure caused by silent ischemia and silent myocardial infarction. Herz, 44(3), 210-217. https://doi.org/10.1007/s00059-019-4798-3

Vigili de Kreutzenberg, S., Solini, A., Vitolo, E., Boi, A., Bacci, S., Cocozza, S., Nappo, R., Rivellese, A., Avogaro, A., & Baroni, M. G. (2017). Silent coronary heart disease in patients with type 2 diabetes: Application of a screening approach in a follow-up study. Journal of Diabetes and its Complications, 31(6), 952-957. https://doi.org/10.1016/j.jdiacomp.2017.03.014

Tavares, C. A., Wajchjenberg, B. L., Rochitte, C., & Lerario, A. C. (2016). Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. Archives of Endocrinology and Metabolism, 60(2), 143-151. https://doi.org/10.1590/2359-3997000000170

Sharda, M, Soni, A. K, Meena, S, Nigam, H, Singh, A. (2016). A prospective study on utility of exercise treadmill test in type 2 diabetes mellitus patients. J Assoc Physicians India. 64(11), 32–7.

Al-Humaidi, G., Sarikaya, I., Elgazzar, A. H., & Owunwanne, A. (2018). Myocardial perfusion abnormalities in asymptomatic type 2 diabetic patients. Journal of the Saudi Heart Association, 30(1), 3-8. https://doi.org/10.1016/j.jsha.2017.04.006

Kisko, A., Lesko, J., Dernarova, L., & Kishko, N. (2020). P979 subclinical left ventricular dysfunction and silent myocardial ischemia in asymptomatic middle-aged patients with type 2 diabetes mellitus. European Heart Journal - Cardiovascular Imaging, 21(Supplement_1). https://doi.org/10.1093/ehjci/jez319.609

Zellweger, M. J., Maraun, M., Osterhues, H. H., Keller, U., Müller-Brand, J., Jeger, R., Pfister, O., Burkard, T., Eckstein, F., Von Felten, S., Osswald, S., & Pfisterer, M. (2014). Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk. JACC: Cardiovascular Imaging, 7(10), 1001-1010. https://doi.org/10.1016/j.jcmg.2014.07.010

Lièvre, M. M., Moulin, P., Thivolet, C., Rodier, M., Rigalleau, V., Penfornis, A., Pradignac, A., & Ovize, M. (2011). Detection of silent myocardial ischemia in asymptomatic patients with diabetes: Results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening. Trials, 12(1). https://doi.org/10.1186/1745-6215-12-23